当前位置:首页 > 股票大全 > 泰林生物 300813 财务分析

泰林生物财务分析

整理编辑：168股票行情网：www.gphq168.com    数据来源：互联网 经供参考

泰林生物(300813)利润表
报告期2024-03-312023-12-312023-09-302023-06-30
营业总收入80,006,616.11269,856,059.81203,117,602.42142,486,385.37
营业总成本77,318,177.9264,005,837.7193,303,198.02125,401,768.97
营业利润5,839,769.8321,778,534.6922,693,621.924,184,406.01
利润总额5,915,782.0721,975,925.3922,878,634.9524,778,880.38
净利润5,541,204.9118,445,191.4820,765,694.3423,006,611.66
其他综合收益----
综合收益总额5,541,204.9118,445,191.4820,765,694.3423,006,611.66
泰林生物(300813)资产负债表
报告期2024-03-312023-12-312023-09-302023-06-30
流动资产合计610,612,858.58638,750,200.42792,012,879.29745,470,195.96
非流动资产合计333,268,262.04334,757,707.45181,468,656.16177,980,023.48
资产总计943,881,120.62973,507,907.87973,481,535.45923,450,219.44
流动负债合计123,362,990.35161,808,999.1150,189,049.4106,055,163.31
非流动负债合计164,682,730.02161,459,731.44157,770,373.93154,183,219.63
负债合计288,045,720.37323,268,730.54307,959,423.33260,238,382.94
归属于母公司股东权益合计654,691,034.97648,762,936.31663,368,369.59660,699,247.55
股东权益合计655,835,400.25650,239,177.33665,522,112.12663,211,836.5
负债和股东权益合计943,881,120.62973,507,907.87973,481,535.45923,450,219.44
泰林生物(300813)现金流量表
报告期2024-03-312023-12-312023-09-302023-06-30
经营活动现金流入小计80,315,376.79348,325,147.14247,875,761.11164,535,726.18
经营活动现金流出小计86,611,769.63346,393,262.63260,386,443.49174,511,267.14
经营活动产生的现金流量净额-6,296,392.841,931,884.51-12,510,682.38-9,975,540.96
投资活动现金流入小计176,994,526.02397,897,984.8121,351,287.240,568,746.57
投资活动现金流出小计176,608,235.15570,241,637.56143,711,828.05131,608,301.63
投资活动产生的现金流量净额386,290.87-172,343,652.76-22,360,540.85-91,039,555.06
筹资活动现金流入小计076,588,926.9276,588,926.9246,588,926.92
筹资活动现金流出小计090,171,511.1758,345,475.3557,891,071.64
筹资活动产生的现金流量净额0-13,582,584.2518,243,451.57-11,302,144.72
汇率变动对现金及现金等价物的影响16,869.98301,016.42-120,099.46-126,803.24
现金及现金等价物净增加额-5,893,231.99-183,693,336.08-16,747,871.12-112,444,043.98
期末现金及现金等价物余额92,036,280.3597,929,512.34265,050,649.87169,178,804.44
泰林生物300813相关数据
今日股市大盘指数